How well does New Zealand commercialise its science? Are there missing bits to our system still, or is the creation of Callaghan Innovation the last big block? What are the relevant measures of success?
This is the fourteenth Moxie session, held Tuesday 1 April 2014 in Auckland.
Interview by Glenn Williams.
An investor’s perspectives
Listen to Moxie Session 14 — Commercialising science on Mixcloud